Compare companies
CSPC Pharmaceutical Group Limited | WuXi AppTec Co., Ltd. | WuXi Biologics (Cayman) Inc. | ||||
---|---|---|---|---|---|---|
Capitalization | ||||||
Price | 5.2 | 72.15 | 27.85 | |||
Price priv. | ||||||
Number of shares, million | 11903.22 | 2692.04 | 4257.5 | |||
Capitalization, billion | 68.68 | 247.52 | 169.22 | |||
EBITDA, billion | 8.66 | 12.47 | 6.22 | |||
EV, billion | 54.29 | 243.24 | 164.61 | |||
Profit and loss report | ||||||
Net profit, billion | 5.87 | 8.71 | 3.4 | |||
Revenue, billion | 31.45 | 36.58 | 17.03 | |||
EPS | 0.4934 | 2.93 | 0.7985 | |||
Balance | ||||||
Assets, billion | 46.28 | 73.46 | 56.58 | |||
Debt, billion | 0.5825 | 5.67 | 4.42 | |||
Balance cost, billion | 33.2 | 54.97 | 40.33 | |||
Cash, billion | 12.02 | 13.73 | 9.67 | |||
Coefficients | ||||||
Dividend yield, % | 5.98 | 3.82 | 0 | |||
Dividend | 0.3 | 1.09 | 0 | |||
Dividend yield priv., % | 0 | 0 | 0 | |||
Dividend priv. | 0 | 0 | 0 | |||
Dividends/profit, % | 46.42 | 31.55 | 0 | |||
P/S | 2.38 | 5.64 | 6.15 | |||
P/BV | 2.13 | 3.73 | 2.38 | |||
P/E | 12.72 | 23.69 | 30.83 | |||
Ev/Ebitda | 7.12 | 17.78 | 26.45 | |||
Debt/Ebitda | 0.0673 | 0.4547 | 0.7106 | |||
Efficiency | ||||||
ROE | 18.53 | 16.95 | 9.02 | |||
ROA | 13.34 | 12.45 | 6.41 | |||
ROIC | 0 | 0 | 0 | |||
Ebitda margin | 27.54 | 34.09 | 36.51 | |||
Net margin | 18.68 | 23.81 | 19.96 | |||
Momentum | ||||||
1 week, price changes | +9.94 % | +17.6 % | +19.53 % | |||
1 month, price changes | +7.66 % | +12.73 % | +15.08 % | |||
3 months, price changes | +8.79 % | +31.42 % | +64.21 % | |||
6 months, price changes | +4.21 % | +69.76 % | +108.15 % | |||
1 year, price changes | -19.88 % | +79.7 % | +96.13 % | |||
3 years, price changes | -31.31 % | -36.15 % | -50.8 % | |||
5 years, price changes | -72.86 % | -37.64 % | -75.72 % | |||
10 years, price changes |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription